戻る Agenda
Reducing Cost and Improving Quality of Clinical Trials
Session Chair(s)
Clara Heering, MS, MSC
Enterprise JJCO lead for Capacity & Alliance Management
Johnson & Johnson, Belgium
Discover three questions to ask before you innovate to reduce cost and improve quality of clinical trials from lessons learned.
Learning Objective : - Define the components of risk-based quality management (RbQM) and data-driven decision making in clinical research - Identify the pitfalls of integration of RBQM into company's processes. - Demonstrate the advantages of a real case study the implementation of RbQM, the advantages of the approach.
Speaker(s)
Evolution of RBM - Risk-Based Quality Management
Artem Andrianov, PHD, MBA
Cyntegrity Germany GmbH, Germany
CEO & Founder
Implementing a Scalable Risk-Based Monitoring Strategy
Richard Davies
CluePoints, Belgium
VP, Solutions Expert
How to drive forward clinical development between Japan and EU?
Hideyuki Kondo, MBA
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Deputy Director, Office of International Program
An Integrated Artificial Intelligence Platform for Clinical Study Management
Manfred Koehler, DRSC
Koehler eClinical GmbH, Germany
CEO